SALISBURY, MO - Federal health inspectors cited Chariton Park Health Care Center for the use of unnecessary psychotropic medications during a complaint investigation completed on November 24, 2025, one of four total deficiencies identified during the inspection. The facility, located in this small central Missouri community, reported correcting the violation by December 8, 2025.
Unnecessary Psychotropic Medications Identified
The Centers for Medicare & Medicaid Services (CMS) cited Chariton Park under regulatory tag F0605, which falls under the federal category of "Freedom from Abuse, Neglect, and Exploitation." Specifically, inspectors determined the facility failed to prevent the use of unnecessary psychotropic medications or the use of medications that may restrain a resident's ability to function.
Psychotropic medications include a broad class of drugs that affect mood, behavior, and cognitive function. This category encompasses antipsychotics, anti-anxiety medications, sedatives, and certain antidepressants. When used without proper clinical justification, these medications can act as a form of chemical restraint, limiting a resident's ability to interact with their environment, make decisions, and carry out daily activities.
Federal regulations under 42 CFR §483.12(a)(2) are explicit: nursing home residents have the right to be free from chemical restraints imposed for purposes of discipline or convenience and that are not required to treat the resident's medical symptoms. The regulation exists because the inappropriate use of psychotropic drugs in nursing homes has been a persistent and well-documented problem across the United States for decades.
The Scope of the Violation
Inspectors classified the deficiency at Scope/Severity Level D, which indicates an isolated incident where no actual harm was documented but where there was potential for more than minimal harm to residents. While this is not the most severe classification on the CMS enforcement scale, the distinction is significant from a medical standpoint.
The four-tier severity system used by CMS ranges from Level A (isolated, no actual harm, with potential for minimal harm) through Level L (widespread, immediate jeopardy to resident health or safety). A Level D finding means that while the violation was limited in scope, the potential consequences were serious enough to warrant regulatory action.
The fact that the citation arose from a complaint investigation rather than a routine annual survey is also notable. Complaint investigations are triggered when concerns are reported to state or federal agencies, meaning someone — whether a resident, family member, staff member, or other party — raised an alarm about practices at the facility.
Why Unnecessary Psychotropic Medications Are Dangerous
The medical risks associated with unnecessary psychotropic medication use in elderly nursing home residents are substantial and well-established in clinical literature. Older adults metabolize drugs differently than younger populations, making them significantly more vulnerable to adverse effects.
Antipsychotic medications, the most commonly flagged class of psychotropic drugs in nursing homes, carry an FDA black box warning — the agency's most serious safety alert — regarding their use in elderly patients with dementia. Studies have demonstrated that antipsychotic use in this population is associated with an increased risk of death, primarily from cardiovascular events and infections such as pneumonia.
Beyond mortality risk, unnecessary psychotropic medications can cause a cascade of harmful effects in elderly residents:
- Excessive sedation can lead to falls, which are a leading cause of injury and death among nursing home residents. Hip fractures resulting from falls carry a one-year mortality rate of approximately 20-30% in elderly populations.
- Cognitive impairment caused by these medications can accelerate mental decline, making it difficult for residents to communicate their needs, participate in care decisions, or engage in social activities.
- Movement disorders such as tardive dyskinesia — involuntary, repetitive movements of the face and body — can develop with prolonged antipsychotic use and may become permanent even after the medication is discontinued.
- Metabolic effects including weight gain, elevated blood sugar, and increased cholesterol levels can compound existing health conditions common in elderly patients.
- Cardiovascular complications including abnormal heart rhythms, low blood pressure upon standing (orthostatic hypotension), and increased stroke risk are documented side effects that pose particular danger in frail elderly residents.
Federal Standards for Psychotropic Medication Use
Federal regulations establish clear requirements for when psychotropic medications may be used in nursing homes and what safeguards must be in place. Under CMS guidelines, facilities are required to meet several conditions before administering these medications:
Clinical justification must be documented. A psychotropic medication should only be prescribed when there is a specific, diagnosed medical condition that warrants its use. Behavioral symptoms alone — such as wandering, restlessness, or calling out — do not automatically justify psychotropic medication.
Non-pharmacological interventions should be attempted first. Before turning to medication, facilities are expected to try behavioral approaches, environmental modifications, activity programming, and other strategies to address the underlying causes of a resident's symptoms. These alternatives might include structured daily routines, increased social interaction, pain management, or modifications to the resident's living environment.
Gradual dose reductions must be attempted periodically. For residents receiving antipsychotic medications, facilities are required to attempt dose reductions at least quarterly during the first year of use, unless clinically contraindicated. This requirement reflects the medical understanding that many behavioral symptoms in elderly residents are situational and may resolve over time.
Informed consent must be obtained. Residents or their legal representatives have the right to be informed about the risks, benefits, and alternatives to psychotropic medications before they are administered.
Ongoing monitoring is required. Facilities must regularly assess residents receiving psychotropic medications for both therapeutic effectiveness and adverse effects, adjusting treatment plans accordingly.
Chemical Restraint Concerns in the Nursing Home Industry
The issue identified at Chariton Park reflects a broader challenge facing the nursing home industry nationwide. The use of psychotropic medications as a means of managing resident behavior — sometimes referred to as chemical restraint — has been the subject of federal enforcement initiatives for over a decade.
In 2012, CMS launched the National Partnership to Improve Dementia Care in Nursing Homes, a major initiative specifically targeting the overuse of antipsychotic medications. At the time, approximately 24% of nursing home residents nationwide were receiving antipsychotic medications. By recent estimates, that figure has decreased to roughly 14%, representing meaningful progress but still indicating that hundreds of thousands of nursing home residents continue to receive these powerful medications.
Staffing levels are frequently cited as a contributing factor. When facilities operate with insufficient numbers of trained staff, there can be pressure — whether explicit or implicit — to manage challenging behaviors pharmacologically rather than through more labor-intensive but less harmful behavioral interventions. Research has consistently shown a correlation between lower staffing ratios and higher rates of psychotropic medication use.
Correction Timeline and Facility Response
Following the November 2025 citation, Chariton Park Health Care Center reported correcting the identified deficiency by December 8, 2025 — approximately two weeks after the inspection. The relatively quick correction timeline suggests the facility took responsive action to address the finding.
However, it is important to note that a reported correction date does not necessarily mean CMS has verified compliance through a follow-up inspection. The regulatory process typically involves the facility submitting a plan of correction to the state survey agency, which may then conduct a revisit to confirm that corrective measures have been implemented and are effective.
The four total deficiencies cited during this inspection indicate that inspectors identified multiple areas of concern beyond the psychotropic medication issue. While the full scope of all citations would provide a more complete picture of the facility's compliance status, the psychotropic medication finding alone raises questions about medication management practices and resident rights protections at the facility.
What Families Should Know
For families with loved ones residing in nursing homes, understanding psychotropic medication use is an important component of advocating for quality care. Key steps include:
Reviewing medication lists regularly. Families should request and review a complete list of all medications their loved one is receiving, including the reason for each prescription. Any psychotropic medication should have a clearly documented clinical justification.
Asking about alternatives. If a psychotropic medication is recommended, families should ask what non-pharmacological approaches have been tried and why medication is considered necessary.
Monitoring for side effects. Changes in a resident's alertness, mobility, appetite, or overall engagement may indicate adverse medication effects and should prompt a conversation with the care team.
Requesting dose reduction attempts. Families have the right to ask whether gradual dose reduction has been attempted, as required by federal regulations.
The full inspection report for Chariton Park Health Care Center, including details of all four cited deficiencies, is available through the CMS Care Compare database and provides additional context about the facility's regulatory compliance history.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Chariton Park Health Care Center from 2025-11-24 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.